A carregar...
The Economic Benefits Resulting from the First 8 Years of the Global Programme to Eliminate Lymphatic Filariasis (2000–2007)
BACKGROUND: Between 2000–2007, the Global Programme to Eliminate Lymphatic Filariasis (GPELF) delivered more than 1.9 billion treatments to nearly 600 million individuals via annual mass drug administration (MDA) of anti-filarial drugs (albendazole, ivermectin, diethylcarbamazine) to all at-risk for...
Na minha lista:
Main Authors: | , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Public Library of Science
2010
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2879371/ https://ncbi.nlm.nih.gov/pubmed/20532228 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0000708 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|